As drugmakers slam Medicare price controls, Wall Street shrugs

Washington Post – Politics:

Drugmakers unleashed a broadside at the Inflation Reduction Act, but most will see minimal impacts from price caps – for now.

This post first appeared in Washington Post – Politics. Read the original article.